CompletedNot Applicable

Normotensive and Hypertensive Placental Abruptions

115 participantsStarted 2016-01-01

Plain-language summary

Placental abruption is a significant cause of both maternal morbidity and neonatal morbidity and mortality. Most abruptions accept to be related to a chronic placental disease process. Therefore, it is very important to understand these processes. To analyze maternal and neonatal effects of placental abruption(PA) through a novel classification in the presence of hypertension. Initial hemoglobin parameters were also compared to predict pregnancy outcomes in addition to hypertension.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * spontaneous, * singleton pregnancies * above 25 weeks of gestations with positive fetal cardiac activity Exclusion Criteria: * multiple gestations, * presence of fetal or maternal infection, * chronic inflammatory diseases or connective tissue disorders * history of myocardial infarction, * thrombosis * history of steroid drug usage.

What they're measuring

blood pressure measurement

Timeframe: 2 minute

Trial details

NCT IDNCT04449601

SponsorHatice Akkaya

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2017-04-30

View on ClinicalTrials.gov More Abruptio Placentae; Affecting Fetus or Newborn trials